Chenxi Yang
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- RNA modifications and cancer
- Enzyme Catalysis and Immobilization
- Congenital heart defects research
- Advanced biosensing and bioanalysis techniques
Papers in
-
- Congenital heart defects research 2
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Hu‐Lin Jiang (6 shared papers)Lei Xing (4 shared papers)Tian‐Jiao Zhou (3 shared papers)Yang Sun (3 shared papers)Nandu Goswami (1 shared paper)Haibo Li (2 shared papers)Xin Chang (1 shared paper)Huiping Wang (1 shared paper)
- Journals
- Frontiers in Endocrinology (5 papers)Phytomedicine (2 papers)Journal of Medical Internet Research (1 paper)European Journal of Medical Genetics (1 paper)Nuclear Engineering and Design (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Chenxi Yang
39 papers receiving 728 citations
Peers
Comparison fields: 5 of 102
- Biomaterials 118
- Molecular Biology 261
- Cancer Research 50
- Pharmaceutical Science 19
- Rehabilitation 18
Countries citing papers authored by Chenxi Yang
This map shows the geographic impact of Chenxi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxi Yang more than expected).
Fields of papers citing papers by Chenxi Yang
This network shows the impact of papers produced by Chenxi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxi Yang. The network helps show where Chenxi Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenxi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 62 | |
| 2 | 2021 | 58 | |
| 3 | 2019 | 54 | |
| 4 | 2019 | 50 | |
| 5 | 2012 | 42 | |
| 6 | 2022 | 39 | |
| 7 | 2014 | 38 | |
| 8 | 2014 | 34 | |
| 9 | 2021 | 32 | |
| 10 | E2F1 transactivates IQGAP3 and promotes proliferation of hepatocellular carcinoma cells through IQGAP3-mediated PKC-alpha activation. | 2019 | 32 |
| 11 | 2013 | 31 | |
| 12 | 2021 | 27 | |
| 13 | 2022 | 26 | |
| 14 | 2016 | 22 | |
| 15 | 2019 | 19 | |
| 16 | 2021 | 16 | |
| 17 | 2023 | 15 | |
| 18 | 2019 | 13 | |
| 19 | 2020 | 13 | |
| 20 | 2022 | 11 |
About Chenxi Yang
Chenxi Yang is a scholar working on Molecular Biology, Biomaterials, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology, having authored 46 papers that have together received 733 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Nanoplatforms for cancer theranostics (3 papers), Cardiac electrophysiology and arrhythmias (2 papers), Congenital heart defects research (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Adipose Tissue and Metabolism (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Biomaterials (118 citations), Molecular Biology (261 citations), Cancer Research (50 citations), Pharmaceutical Science (19 citations) and Rehabilitation (18 citations). Chenxi Yang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Hu‐Lin Jiang, Lei Xing, Tian‐Jiao Zhou, Yang Sun, Nandu Goswami, Haibo Li, Xin Chang, Huiping Wang, Hui Ming Ge and Zhiqiang Yu. Their work appears in journals such as Frontiers in Endocrinology, Phytomedicine, Journal of Medical Internet Research, European Journal of Medical Genetics and Nuclear Engineering and Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.